Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles

Brucellosis is a highly contagious zoonosis chronic infectious disease with a strong latent capability to endanger human health and economic development via direct or indirect ways. However, the existing methods for brucellosis diagnosis are time-consuming and expensive as they require a tedious exp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lirui Ge, Dan Wang, Fengnan Lian, Jinbin Zhao, Yue Wang, Yuyi Zhao, Lanting Zhang, Juan Wang, Xiuling Song, Jinhua Li, Kun Xu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/d6204622354a4f0db05ad69809869116
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d6204622354a4f0db05ad69809869116
record_format dspace
spelling oai:doaj.org-article:d6204622354a4f0db05ad698098691162021-12-03T04:44:30ZLateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles2297-176910.3389/fvets.2021.771341https://doaj.org/article/d6204622354a4f0db05ad698098691162021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.771341/fullhttps://doaj.org/toc/2297-1769Brucellosis is a highly contagious zoonosis chronic infectious disease with a strong latent capability to endanger human health and economic development via direct or indirect ways. However, the existing methods for brucellosis diagnosis are time-consuming and expensive as they require a tedious experimental procedure and a sophisticated experimental device and performance. To overcome these defects, it is truly necessary to establish a real-time, on-site, and rapid detection method for human brucellosis. Here, a lateral flow immunoassay (LFIA) with a rapid, sensitive, and alternative diagnostic procedure for human brucellosis with a high degree of accuracy was developed based on blue silica nanoparticles (SiNPs), Staphylococcal protein A (SPA), and surface Lipopolysaccharide of Brucella spp. (LPS), which can be applied for rapid and feasible detection of human brucellosis. To our knowledge, this is the first report that uses blue SiNPs as a signal probe of LFIA for the rapid diagnosis of human brucellosis. The precursor of blue SiNPs@SPA such as colorless SiNPs and blue SiNPs was synthesized at first and then coupled with SPA onto the surface of blue SiNPs by covalent bond to prepare blue SiNPs@SPA as a capture signal to catch the antibody in the brucellosis-positive serum. When SPA was combined with the antibodies in the brucellosis-positive serum, it was captured by LPS on the test line, forming an antigen–antibody sandwich structure, resulting in the T line turning blue. Finally, the results showed that it is acceptable to use blue SiNPs as visible labels of LFIA, and standard brucellosis serum (containing Brucella spp. antibody at 1,000 IU/ml) could be detected at a dilution of 10−5 and the detection limit of this method was 0.01 IU/ml. Moreover, it also demonstrated good specificity and accuracy for the detection of real human serum samples. Above all, the blue SiNPs-based LFIA that we developed provides a rapid, highly accurate, and inexpensive on-site diagnosis of human brucellosis, and shows great promise in clinical diagnostics for other diseases.Lirui GeLirui GeDan WangDan WangFengnan LianFengnan LianJinbin ZhaoJinbin ZhaoYue WangYue WangYuyi ZhaoYuyi ZhaoLanting ZhangJuan WangXiuling SongJinhua LiKun XuKun XuFrontiers Media S.A.articleblue SiNPsLFIAhuman brucellosisantigen-antibody sandwich structureBrucella spp.Veterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic blue SiNPs
LFIA
human brucellosis
antigen-antibody sandwich structure
Brucella spp.
Veterinary medicine
SF600-1100
spellingShingle blue SiNPs
LFIA
human brucellosis
antigen-antibody sandwich structure
Brucella spp.
Veterinary medicine
SF600-1100
Lirui Ge
Lirui Ge
Dan Wang
Dan Wang
Fengnan Lian
Fengnan Lian
Jinbin Zhao
Jinbin Zhao
Yue Wang
Yue Wang
Yuyi Zhao
Yuyi Zhao
Lanting Zhang
Juan Wang
Xiuling Song
Jinhua Li
Kun Xu
Kun Xu
Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
description Brucellosis is a highly contagious zoonosis chronic infectious disease with a strong latent capability to endanger human health and economic development via direct or indirect ways. However, the existing methods for brucellosis diagnosis are time-consuming and expensive as they require a tedious experimental procedure and a sophisticated experimental device and performance. To overcome these defects, it is truly necessary to establish a real-time, on-site, and rapid detection method for human brucellosis. Here, a lateral flow immunoassay (LFIA) with a rapid, sensitive, and alternative diagnostic procedure for human brucellosis with a high degree of accuracy was developed based on blue silica nanoparticles (SiNPs), Staphylococcal protein A (SPA), and surface Lipopolysaccharide of Brucella spp. (LPS), which can be applied for rapid and feasible detection of human brucellosis. To our knowledge, this is the first report that uses blue SiNPs as a signal probe of LFIA for the rapid diagnosis of human brucellosis. The precursor of blue SiNPs@SPA such as colorless SiNPs and blue SiNPs was synthesized at first and then coupled with SPA onto the surface of blue SiNPs by covalent bond to prepare blue SiNPs@SPA as a capture signal to catch the antibody in the brucellosis-positive serum. When SPA was combined with the antibodies in the brucellosis-positive serum, it was captured by LPS on the test line, forming an antigen–antibody sandwich structure, resulting in the T line turning blue. Finally, the results showed that it is acceptable to use blue SiNPs as visible labels of LFIA, and standard brucellosis serum (containing Brucella spp. antibody at 1,000 IU/ml) could be detected at a dilution of 10−5 and the detection limit of this method was 0.01 IU/ml. Moreover, it also demonstrated good specificity and accuracy for the detection of real human serum samples. Above all, the blue SiNPs-based LFIA that we developed provides a rapid, highly accurate, and inexpensive on-site diagnosis of human brucellosis, and shows great promise in clinical diagnostics for other diseases.
format article
author Lirui Ge
Lirui Ge
Dan Wang
Dan Wang
Fengnan Lian
Fengnan Lian
Jinbin Zhao
Jinbin Zhao
Yue Wang
Yue Wang
Yuyi Zhao
Yuyi Zhao
Lanting Zhang
Juan Wang
Xiuling Song
Jinhua Li
Kun Xu
Kun Xu
author_facet Lirui Ge
Lirui Ge
Dan Wang
Dan Wang
Fengnan Lian
Fengnan Lian
Jinbin Zhao
Jinbin Zhao
Yue Wang
Yue Wang
Yuyi Zhao
Yuyi Zhao
Lanting Zhang
Juan Wang
Xiuling Song
Jinhua Li
Kun Xu
Kun Xu
author_sort Lirui Ge
title Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
title_short Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
title_full Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
title_fullStr Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
title_full_unstemmed Lateral Flow Immunoassay for Visible Detection of Human Brucellosis Based on Blue Silica Nanoparticles
title_sort lateral flow immunoassay for visible detection of human brucellosis based on blue silica nanoparticles
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/d6204622354a4f0db05ad69809869116
work_keys_str_mv AT liruige lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT liruige lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT danwang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT danwang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT fengnanlian lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT fengnanlian lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT jinbinzhao lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT jinbinzhao lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT yuewang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT yuewang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT yuyizhao lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT yuyizhao lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT lantingzhang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT juanwang lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT xiulingsong lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT jinhuali lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT kunxu lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
AT kunxu lateralflowimmunoassayforvisibledetectionofhumanbrucellosisbasedonbluesilicananoparticles
_version_ 1718373958032556032